Ipratropium should be used with caution in which patients?

• A. Pediatric patients under 2
• B. Elderly patients
• C. Both elderly and cardiovascular/hypertension patients
• D. Patients with cardiovascular disease or hypertension

Answer: (C)

Ipratropium is an inhaled anticholinergic bronchodilator, so it can cause anticholinergic side effects such as increased heart rate and palpitations, along with dry mouth and throat irritation. These effects pose more risk in people who are elderly, who are more sensitive to these drugs and often take multiple medications, and in people with cardiovascular disease or hypertension, where a faster heart rate or blood pressure changes can worsen their condition. Because both groups are at heightened risk, the option that includes elderly patients plus those with cardiovascular disease or hypertension best identifies who should be used with caution. The other options focus on only one group, either the elderly or cardiovascular disease/hypertension alone, and miss the broader at-risk population.